Neurodevelopment not impacted by glucocorticoids in preemies

January 11, 2018

(HealthDay)—Use of inhaled glucocorticoids in extremely preterm infants for the prevention of bronchopulmonary dysplasia does not lead to a higher rate of neurodevelopmental disability at 2 years, according to a study published in the Jan. 11 issue of the New England Journal of Medicine.

Dirk Bassler, M.D., from University of Zurich, and colleagues randomly assigned 863 infants (gestational age, 23 weeks 0 days to 27 weeks 6 days) to receive early (within 24 hours after birth) inhaled budesonide or placebo. A long-term composite outcome of neurodevelopmental disability among survivors included , cognitive delay (a Mental Development Index score of <85 on the Bayley Scales of Infant Development, Second Edition), deafness, or blindness at a corrected age of 18 to 22 months.

Based on follow-up data from 629 infants, the researchers found that 148 of 308 infants assigned to budesonide had neurodevelopmental disability versus 165 of 321 infants assigned to placebo (relative risk, adjusted for , 0.93; 95 percent confidence interval, 0.80 to 1.09; P = 0.40). For individual components of the composite outcome there was similarly no significant differences. However, there were more deaths among infants randomized to budesonide, compared to those given placebo (relative risk, 1.37; 95 percent confidence interval, 1.01 to 1.86; P = 0.04).

"We found no effect of budesonide on the risk of neurodevelopmental disability among surviving extremely preterm infants at 18 to 22 months of age," the authors write. "However, the mortality rate was higher in the budesonide group."

The research was funded by Chiesi Farmaceutici, which provided the study drugs free of charge.

Explore further: Budesonide may be beneficial in extremely preterm infants

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Budesonide may be beneficial in extremely preterm infants

October 15, 2015
(HealthDay)—For extremely premature infants, early inhaled budesonide is associated with reduced incidence of bronchopulmonary dysplasia but may be linked to increased mortality, according to a study published online Oct. ...

EPO in very preterm infants does not improve neurodevelopmental outcomes at two years

May 17, 2016
In a study appearing in the May 17 issue of JAMA, Giancarlo Natalucci, M.D., of the University of Zurich, Switzerland, and colleagues randomly assigned 448 preterm infants born between 26 weeks 0 days' and 31 weeks 6 days' ...

Administration of steroid to extremely preterm infants not associated with adverse effects on neurod

April 4, 2017
The administration of low-dose hydrocortisone to extremely preterm infants was not associated with any adverse effects on neurodevelopmental outcomes at 2 years of age, according to a study published by JAMA.

Enteral DHA doesn't cut preemie bronchopulmonary dysplasia risk

March 30, 2017
(HealthDay)—Enteral docosahexaenoic acid (DHA) supplementation does not reduce the risk of bronchopulmonary dysplasia for infants born before 29 weeks of gestation, according to a study published in the March 30 issue of ...

Study examines neurodevelopmental outcomes for children born extremely preterm

April 30, 2013
Fredrik Serenius, M.D., Ph.D., of Uppsala University, Uppsala, Sweden, and colleagues conducted a study to assess neurological and developmental outcome in extremely preterm (less than 27 gestational weeks) children at 2.5 ...

Hypoxia challenge test can ID fitness to fly in neonates

February 16, 2016
(HealthDay)—Many infants with bronchopulmonary dysplasia (BPD) fail hypoxia challenge testing (HCT) and cannot be deemed fit to fly, according to a study published online Feb. 15 in Pediatrics.

Recommended for you

Early childhood interventions show mixed results on child development

April 24, 2018
Early childhood interventions may have some efficacy in boosting measures of child health and development in low income countries, but more work is needed to sort out how to implement these interventions, according to a new ...

New study shows prenatal cannabis use associated with low birth weights

April 23, 2018
With marijuana use during pregnancy on the rise, a new study led by the Colorado School of Public Health shows that prenatal cannabis use was associated with a 50 percent increased likelihood of low birth weight, setting ...

New research suggests possible link between sudden infant death syndrome and air pollution

April 20, 2018
A study led by the University of Birmingham suggests a possible association between exposure to certain pollutants and an increased risk of so-called 'cot death'.

Common antidepressants in pregnancy may alter fetal brain development

April 10, 2018
(HealthDay)—Pregnant women who take certain antidepressants may unknowingly compromise the brain development of their child, researchers suggest.

Kids in tough neighborhoods head to ER more often

April 6, 2018
(HealthDay)—Growing up in a disadvantaged neighborhood may mean more visits to the emergency room, a new study suggests.

Infant death study reveals dangerous sleep practices among babysitters, relatives, others

April 2, 2018
Babies who died during their sleep while being watched by someone other than parents often had been placed in unsafe sleep positions, such as on their stomachs, or in unsafe locations, such as a couch, a new study has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.